Literature DB >> 20890271

SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors.

José Gaal1, Constantine A Stratakis, J Aidan Carney, Evan R Ball, Esther Korpershoek, Maya B Lodish, Isaac Levy, Paraskevi Xekouki, Francien H van Nederveen, Michael A den Bakker, Maureen O'Sullivan, Winand N M Dinjens, Ronald R de Krijger.   

Abstract

Mutations in the tumor suppressor genes SDHB, SDHC, and SDHD (or collectively SDHx) cause the inherited paraganglioma syndromes, characterized by pheochromocytomas and paragangliomas. However, other tumors have been associated with SDHx mutations, such as gastrointestinal stromal tumors (GISTs) specifically in the context of Carney-Stratakis syndrome. Previously, we have shown that SDHB immunohistochemistry is a reliable technique for the identification of pheochromocytomas and paragangliomas caused by SDHx mutations. We hypothesized that GISTs in patients with SDHx mutations would be negative immunohistochemically for SDHB as well. Four GISTs from patients with Carney-Stratakis syndrome and six from patients with Carney triad were investigated by SDHB immunohistochemistry. Five GISTs with KIT or PDGFRA gene mutations were used as controls. In addition, SDHB immunohistochemistry was performed on 42 apparently sporadic GISTs. In cases in which the SDHB immunohistochemistry was negative, mutational analysis of SDHB, SDHC, and SDHD was performed. All GISTs from patients with Carney-Stratakis syndrome and Carney triad were negative for SDHB immunohistochemically. In one patient with Carney-Stratakis syndrome, a germline SDHB mutation was found (p.Ser92Thr). The five GISTs with a KIT or PDGFRA gene mutation were all immunohistochemically positive for SDHB. Of the 42 sporadic tumors, one GIST was SDHB-negative. Mutational analysis of this tumor did not reveal an SDHx mutation. All SDHB-negative GISTs were located in the stomach, had an epithelioid morphology, and had no KIT or PDGFRA mutations. We show that Carney-Stratakis syndrome- and Carney-triad-associated GISTs are negative by immunohistochemistry for SDHB in contrast to KIT- or PDGFRA-mutated GISTs and a majority of sporadic GISTs. We suggest that GISTs of epithelioid cell morphology are tested for SDHB immunohistochemically. In case of negative SDHB staining in GISTs, Carney-Stratakis syndrome or Carney triad should be considered and appropriate clinical surveillance should be instituted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890271      PMCID: PMC3415983          DOI: 10.1038/modpathol.2010.185

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  17 in total

Review 1.  Succinate:quinone oxidoreductases: an overview.

Authors:  C Roy D Lancaster
Journal:  Biochim Biophys Acta       Date:  2002-01-17

2.  Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome.

Authors:  B Parfait; D Chretien; A Rötig; C Marsac; A Munnich; P Rustin
Journal:  Hum Genet       Date:  2000-02       Impact factor: 4.132

3.  Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.

Authors:  Anthony J Gill; Diana E Benn; Angela Chou; Adele Clarkson; Anita Muljono; Goswin Y Meyer-Rochow; Anne Louise Richardson; Stan B Sidhu; Bruce G Robinson; Roderick J Clifton-Bligh
Journal:  Hum Pathol       Date:  2010-03-17       Impact factor: 3.466

4.  Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types.

Authors:  Anthony J Gill; Angela Chou; Ricardo Vilain; Adele Clarkson; Millie Lui; Richard Jin; Vivienne Tobias; Jaswinder Samra; David Goldstein; Celia Smith; Loretta Sioson; Nicole Parker; Ross C Smith; Mark Sywak; Stan B Sidhu; Jenny Ma Wyatt; Bruce G Robinson; Robert P Eckstein; Diana E Benn; Roderick J Clifton-Bligh
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

5.  A gastrointestinal stromal tumor in a patient with multiple endocrine neoplasia type 2A and metastatic medullary thyroid cancer to the ovaries.

Authors:  Rana Malek; Desiree McCarthy-Keith; Eric D Levens; Maria J Merino; Alan H DeCherney; Lee S Weinstein
Journal:  Endocr Pract       Date:  2008-10       Impact factor: 3.443

6.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.

Authors:  Hartmut P H Neumann; Christian Pawlu; Mariola Peczkowska; Birke Bausch; Sarah R McWhinney; Mihaela Muresan; Mary Buchta; Gerlind Franke; Joachim Klisch; Thorsten A Bley; Stefan Hoegerle; Carsten C Boedeker; Giuseppe Opocher; Jörg Schipper; Andrzej Januszewicz; Charis Eng
Journal:  JAMA       Date:  2004-08-25       Impact factor: 56.272

7.  An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.

Authors:  Francien H van Nederveen; José Gaal; Judith Favier; Esther Korpershoek; Rogier A Oldenburg; Elly M C A de Bruyn; Hein F B M Sleddens; Pieter Derkx; Julie Rivière; Hilde Dannenberg; Bart-Jeroen Petri; Paul Komminoth; Karel Pacak; Wim C J Hop; Patrick J Pollard; Massimo Mannelli; Jean-Pierre Bayley; Aurel Perren; Stephan Niemann; Albert A Verhofstad; Adriaan P de Bruïne; Eamonn R Maher; Frédérique Tissier; Tchao Méatchi; Cécile Badoual; Jérôme Bertherat; Laurence Amar; Despoina Alataki; Eric Van Marck; Francesco Ferrau; Jerney François; Wouter W de Herder; Mark-Paul F M Vrancken Peeters; Anne van Linge; Jacques W M Lenders; Anne-Paule Gimenez-Roqueplo; Ronald R de Krijger; Winand N M Dinjens
Journal:  Lancet Oncol       Date:  2009-07-01       Impact factor: 41.316

8.  Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach.

Authors:  Ryoji Takahashi; Shinji Tanaka; Yasuhiko Kitadai; Masaharu Sumii; Masaharu Yoshihara; Ken Haruma; Kazuaki Chayama
Journal:  Oncology       Date:  2003       Impact factor: 2.935

9.  Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.

Authors:  Umasuthan Srirangalingam; Lisa Walker; Bernard Khoo; Fiona MacDonald; Daphne Gardner; Terence J Wilkin; Robert H Skelly; Emad George; David Spooner; John P Monson; Ashley B Grossman; Scott A Akker; Patrick J Pollard; Nick Plowman; Norbert Avril; Daniel M Berney; Jacky M Burrin; Rodney H Reznek; V K Ajith Kumar; Eamonn R Maher; Shern L Chew
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-14       Impact factor: 3.478

Review 10.  Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors.

Authors:  J Aidan Carney
Journal:  J Clin Endocrinol Metab       Date:  2009-09-01       Impact factor: 5.958

View more
  50 in total

1.  Carney Stratakis syndrome in a patient with SDHD mutation.

Authors:  Carmen Tenorio Jiménez; Louise Izatt; Fuju Chang; Mufaddal T Moonim; Paul V Carroll; Barbara M McGowan
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

2.  SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

Authors:  Thomas G Papathomas; Lindsey Oudijk; Alexandre Persu; Anthony J Gill; Francien van Nederveen; Arthur S Tischler; Frédérique Tissier; Marco Volante; Xavier Matias-Guiu; Marcel Smid; Judith Favier; Elena Rapizzi; Rosella Libe; Maria Currás-Freixes; Selda Aydin; Thanh Huynh; Urs Lichtenauer; Anouk van Berkel; Letizia Canu; Rita Domingues; Roderick J Clifton-Bligh; Magdalena Bialas; Miikka Vikkula; Gustavo Baretton; Mauro Papotti; Gabriella Nesi; Cécile Badoual; Karel Pacak; Graeme Eisenhofer; Henri J Timmers; Felix Beuschlein; Jérôme Bertherat; Massimo Mannelli; Mercedes Robledo; Anne-Paule Gimenez-Roqueplo; Winand Nm Dinjens; Esther Korpershoek; Ronald R de Krijger
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

3.  Carney triad can be (rarely) associated with germline succinate dehydrogenase defects.

Authors:  Sosipatros A Boikos; Paraskevi Xekouki; Elena Fumagalli; Fabio R Faucz; Margarita Raygada; Eva Szarek; Evan Ball; Su Young Kim; Markku Miettinen; Lee J Helman; J Aidan Carney; Karel Pacak; Constantine A Stratakis
Journal:  Eur J Hum Genet       Date:  2015-07-15       Impact factor: 4.246

Review 4.  The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.

Authors:  Sosipatros A Boikos; Constantine A Stratakis
Journal:  Endocrine       Date:  2014-07-16       Impact factor: 3.633

Review 5.  Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Authors:  Lauren Fishbein; Katherine L Nathanson
Journal:  Cancer Genet       Date:  2012 Jan-Feb

6.  Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase.

Authors:  Sounak Gupta; Jun Zhang; Lori A Erickson
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

Review 7.  Succinate dehydrogenase-deficient gastrointestinal stromal tumors.

Authors:  Ya-Mei Wang; Meng-Li Gu; Feng Ji
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

8.  Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms.

Authors:  Markku Miettinen; Maarit Sarlomo-Rikala; Peter McCue; Piotr Czapiewski; Renata Langfort; Piotr Waloszczyk; Krzysztof Wazny; Wojciech Biernat; Jerzy Lasota; Zengfeng Wang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-01

Review 9.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

10.  [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].

Authors:  A Agaimy
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.